NCT06500741View on ClinicalTrials.gov

Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cancer Patients

CompletedOBSERVATIONAL

Enrollment

374

Participants

Timeline

Start Date

November 22, 2024

Primary Completion Date

April 2, 2025

Study Completion Date

April 2, 2025

Conditions

Prostate Cancer

Interventions

OTHER

No Intervention

No investigational drug will be administered to participants in this study.

Trial Locations (1)

02199

Analysis Group, Inc., Boston

All Listed Sponsors

lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT06500741 - Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cancer Patients | Biotech Hunter | Biotech Hunter